Sign In
Buy ADVM
$4.36
+0 (+0%)
At Close: Mar 06, 2026
Morgan Stanley Sells 365,722 Shares of Editas Medicine Inc (NASDAQ:EDIT)
06:16am, Friday, 03'rd Jul 2020
Morgan Stanley lowered its stake in Editas Medicine Inc (NASDAQ:EDIT) by 32.4% in the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The
Regeneron stops trial after drug fails to help coronavirus patients
08:57pm, Thursday, 02'nd Jul 2020
Kevzara fared no better than the placebo.
The Number of Covid-19 Cases Is Rising. What Comes Next.
08:37pm, Thursday, 02'nd Jul 2020
Governments face a major challenge as cases surge: whether or not to lock down. Meanwhile, the market hangs on news of a number of vaccine makers preparing to launch larger clinical trials. The next w
Nasdaq Smashes All-Time High as Tech Stocks Remain Immune to Virus Risk
04:45pm, Thursday, 02'nd Jul 2020
The Nasdaq Composite Index continues to be Wall Street's standout performer. Following Thursday's rally, the index is up 14% year-to-date.
Better Buy: Editas Medicine vs. Intellia | The Motley Fool
03:32pm, Thursday, 02'nd Jul 2020
Which of these companies that are developing cutting-edge gene-editing technologies is the better buy for investors?
Axa Sells 10,438 Shares of Regeneron Pharmaceuticals Inc (NASDAQ:REGN)
06:16am, Thursday, 02'nd Jul 2020
Axa cut its position in Regeneron Pharmaceuticals Inc (NASDAQ:REGN) by 11.1% in the 1st quarter, Holdings Channel.com reports. The institutional investor owned 83,341 shares of the biopharmaceutical c
Some government Covid-19 contracts could skirt affordable pricing laws
11:00am, Wednesday, 01'st Jul 2020
The use of such contracts could allow authorities to bypass laws that could ensure taxpayer-funded medicines or vaccines are affordable.
Regeneron Pharmaceuticals Inc (NASDAQ:REGN) Director George L. Sing Sells 3,000 Shares
04:20am, Wednesday, 01'st Jul 2020
Regeneron Pharmaceuticals Inc (NASDAQ:REGN) Director George L. Sing sold 3,000 shares of the stock in a transaction that occurred on Monday, June 29th. The stock was sold at an average price of $608.9
S&P 500's resilience reflects corporate dynamism, why investors must diversify
09:50pm, Tuesday, 30'th Jun 2020
WITH the benefit of hindsight, the five largest components of the S&P 500 index were a good place to shelter from the Covid-19 turmoil that caused a global economic slump. Read more at The Business Ti
Regeneron Pharmaceuticals Has Made a Major Upside Breakout
05:28pm, Tuesday, 30'th Jun 2020
Now that REGN has clearly broken out above the highs of 2015 there is no chart resistance.
Analyzing Avrobio (NASDAQ:AVRO) & Editas Medicine (NASDAQ:EDIT)
02:54am, Tuesday, 30'th Jun 2020
Avrobio (NASDAQ:AVRO) and Editas Medicine (NASDAQ:EDIT) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their ins
Regeneron’s Billionaire Cofounder Criticized After ‘All Lives Matter’ Graduation Speech
12:00am, Tuesday, 30'th Jun 2020
Speaking at a high school graduation in Yorktown, NY, Regeneron cofounder and Chief Scientific Officer Dr. George Yancopoulos said that police are “scapegoats” for larger race issues.
Kiniksa Pharmaceuticals, Ltd. : Des résultats prometteurs pour le Rilonacept | Zone bourse
04:01pm, Monday, 29'th Jun 2020Covid Cases Are Rising Faster Than Ever in the U.S.
12:07pm, Monday, 29'th Jun 2020
A broader push for masks, another big advertiser halts spending on Facebook, the top CEOs of 2020, and other news to start your day.
